Human volunteers will soon begin receiving an HIV vaccine that contains an adjuvant developed in Irvine’s lab, which helps to boost B cell responses to the vaccine. An MIT research team led by Professor Darrell Irvine has developed a novel kind of...

Darrell gives an interview on our exciting SMNP HIV vaccine adjuvant!
read more